
Opportunity Radar
Where technical capability, quantified economic need, technological regimes, and bottleneck states meet — a full-stack translation radar.
Read more
31technologies with real economic-need data0high-capability, not-yet-evidenced3valley-of-death capital gaps
Technological Regimes: Classifies industries into Entrepreneurial (Schumpeter Mark I) vs. Routinized (Schumpeter Mark II) regimes, explaining why capital-intensive physics/semiconductor sectors demand basic science while software recombines existing tools.
5-Stage Bottleneck State Machine: Pinpoints whether a technology is Science Blocked, Enablement Blocked, Valley of Death, Regime Mismatch, or Commercially Diffusing.
| Technology | Industry | Regime | Capability | Economic Need | Adoption Events | Translation Latency | Bottleneck State | Hurdle Tier |
|---|---|---|---|---|---|---|---|---|
| Shape Memory Alloys | Smart Metals | hybrid | 0.229 | $40.7B🛡️ Audit | 19 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Self-Driving Vehicles | Autonomous Mobility | hybrid | 0.524 | $36.5B🛡️ Audit* | 28 | 8 yr | Commercially Diffusing | High capability, has evidence |
| AI Materials Discovery | Computational Materials | hybrid | 0.328 | $36.0B🛡️ Audit | 5 | 8 yr | Commercially Diffusing | High capability, has evidence |
| Quantum Dots | Nanomaterials & Optoelectronics | hybrid | 0.254 | $24.7B🛡️ Audit* | 16 | 8 yr | Commercially Diffusing | High capability, has evidence |
| General-Purpose Robotics | Robotics & Physical AI | hybrid | 0.200 | $22.8B🛡️ Audit | 20 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| High-Entropy Alloys | Advanced Alloys | hybrid | — | $19.8B🛡️ Audit | 8 | 8 yr | Commercially Diffusing | Insufficient data |
| Neural Interfaces | Neurotechnology | hybrid | 0.339 | $13.5B🛡️ Audit* | 11 | 8 yr | Commercially Diffusing | High capability, has evidence |
| Generative AI | Artificial Intelligence | routinized | 0.303 | $12.9B🛡️ Audit | 24 | 14.5 yr | Commercially Diffusing | High capability, has evidence |
| Foundation Models | Artificial Intelligence | routinized | 0.162 | $11.2B🛡️ Audit | 102 | 3.8 yr | Commercially Diffusing | Low capability, has evidence |
| Metamaterials | Engineered Structures | hybrid | — | $8.1B🛡️ Audit* | 13 | 8 yr | Commercially Diffusing | Insufficient data |
| Graphene | 2D Materials & Nanomaterials | hybrid | 0.322 | $8.1B🛡️ Audit* | 32 | 0 yr | Commercially Diffusing | High capability, has evidence |
| MXenes | 2D Materials & Nanomaterials | hybrid | — | $8.1B🛡️ Audit* | 14 | 8 yr | Commercially Diffusing | Insufficient data |
| Gene Editing | Genomics | hybrid | 0.486 | $6.3B🛡️ Audit* | 76 | 0 yr | Commercially Diffusing | High capability, has evidence |
| Autonomous Agents | Artificial Intelligence | routinized | 0.248 | $5.7B🛡️ Audit | 27 | 14.5 yr | Commercially Diffusing | Low capability, has evidence |
| Next-Gen Batteries | Energy Storage | routinized | 0.355 | $5.5B🛡️ Audit | 21 | 14.5 yr | Commercially Diffusing | High capability, has evidence |
| Self-Healing Polymers | Smart Materials | hybrid | — | $5.5B🛡️ Audit | 6 | 8 yr | Commercially Diffusing | Insufficient data |
| Nuclear Fusion | Clean Energy Generation | hybrid | 0.149 | $4.7B🛡️ Audit | 33 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Perovskite Solar Cells | Photovoltaic Materials | hybrid | 0.201 | $4.6B🛡️ Audit | 26 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Recurrent Neural Networks (LSTM) | Artificial Intelligence | routinized | — | $4.5B🛡️ Audit | 6 | 14.5 yr | Commercially Diffusing | Insufficient data |
| AI-Accelerated Drug Discovery | Drug Development | hybrid | 0.184 | $4.5B🛡️ Audit | 8 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Quantum Computing | Semiconductors | routinized | 0.214 | $3.0B🛡️ Audit* | 74 | 11 yr | Commercially Diffusing | Low capability, has evidence |
| Nuclear Fission | Nuclear Energy Generation | routinized | 0.032 | $2.8B🛡️ Audit | 36 | 14.5 yr | Commercially Diffusing | Low capability, has evidence |
| Nanocellulose | Bio-Based Materials | hybrid | 0.209 | $2.7B🛡️ Audit | 22 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Metal-Organic Frameworks | Porous Materials | hybrid | 0.495 | $2.7B🛡️ Audit | 15 | 8 yr | Commercially Diffusing | High capability, has evidence |
| Aerogels | Ultra-Lightweight & Insulation Materials | hybrid | 0.252 | $2.7B🛡️ Audit | 23 | 8 yr | Commercially Diffusing | High capability, has evidence |
| Convolutional Sequence Models (ConvS2S) | Artificial Intelligence | routinized | — | $2.5B🛡️ Audit | 0 | 14.5 yr | Valley of Death | Insufficient data |
| mRNA Platform | Drug Development | hybrid | 0.353 | $2.0B🛡️ Audit | 22 | 8 yr | Commercially Diffusing | High capability, has evidence |
| AI Hardware | Artificial Intelligence | routinized | — | $1.5B🛡️ Audit | 0 | 14.5 yr | Valley of Death | Insufficient data |
| Carbon Fiber | Advanced Composites | hybrid | 0.231 | $801M🛡️ Audit | 16 | 8 yr | Commercially Diffusing | Low capability, has evidence |
| Advanced Chip Manufacturing | Semiconductors | routinized | — | $557M🛡️ Audit | 0 | 14.5 yr | Valley of Death | Insufficient data |
| Advanced Semiconductor Fabrication | Semiconductors | routinized | 0.427 | $557M🛡️ Audit | 90 | 14.5 yr | Commercially Diffusing | High capability, has evidence |